Table 4 Change in medical data from baseline to 2-year follow-up in the SLS and the control groups.
Continuous variables | Changes | P-value | |
|---|---|---|---|
SLS (n = 792) | Control (n = 3645) | ||
Mean ± SE | Mean ± SE | ||
BW (kg) | −1.52 ± 0.23 | −0.01 ± 0.07 | <0.001*** |
BMI (kg/m2) | −0.52 ± 0.08 | 0.03 ± 0.03 | <0.001*** |
WC (cm) | −1.04 ± 0.25 | 0.30 ± 0.08 | <0.001*** |
SBP (mmHg) | 1.08 ± 0.93 | 0.64 ± 0.28 | 0.643 |
DBP (mmHg) | 0.11 ± 0.58 | 0.38 ± 0.18 | 0.658 |
TG (mg/dl) | −16.73 ± 5.95 | −2.51 ± 2.04 | 0.026* |
HDL-C (mg/dl) | 3.38 ± 0.57 | 0.90 ± 0.18 | <0.001*** |
LDL-C (mg/dl) | −4.90 ± 1.61 | −1.99 ± 0.57 | 0.084 |
FPG (mg/dl) | −0.08 ± 1.57 | 3.42 ± 0.51 | 0.026* |
HbA1c (%) | −0.01 ± 0.03 | 0.11 ± 0.01 | 0.000** |
AST (IU/l) | −1.53 ± 0.61 | −0.02 ± 0.33 | 0.025* |
ALT (IU/l) | −4.34 ± 1.01 | −1.20 ± 0.48 | 0.004* |
γGTP (IU/l) | −6.14 ± 1.97 | 0.02 ± 0.81 | 0.002* |